Hongbo Pharmaceuticals: Net profit in the first half of 2025 was 24.7614 million yuan, a year-on-year increase of 54.99%.

Hongbo Pharmaceuticals announced that in the first half of 2025, its operating income was 353 million yuan, a year-on-year increase of 32.73%. Net profit was 24.7614 million yuan, a year-on-year increase of 54.99%. The company plans to distribute cash dividends of 0.7 yuan for every 10 shares to all shareholders, without issuing bonus shares or increasing share capital from reserves when implementing profit distribution program on the registration date of stock rights.